India s Cipla Given Approval to Distribute Moderna s COVID-19 Vaccine
Voice of America
30 Jun 2021, 07:35 GMT+10
Indian officials announced Tuesday that Indian pharmaceutical company Cipla has been approved to distribute its partner Moderna s COVID-19 vaccine, as the country seeks to ramp up its vaccination program to prevent a third wave of the virus.
The authorization will now allow the Moderna vaccine to be imported into India. It will be the fourth COVID-19 vaccine given emergency approval for use in the country, after AstraZeneca and partner Serum Institute of India s Covishield, Bharat Biotech s Covaxin and Russian-developed Sputnik V.
So far, India has administered about 330 million doses, more than the overall shots administered in the United States. But with a population of 1.36 billion, the vaccination rate is much lower than several other countries. India has the world s second-highest number of infections, with more than 30 million cases and almost 398,000 deaths.
India s Cipla Given Approval to Distribute Moderna s COVID-19 Vaccine
newzealandstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newzealandstar.com Daily Mail and Mail on Sunday newspapers.
Investegate | Company News | Corporate, London Stock Exchange, Regulatory News Headlines City Pub trading at 90% of 2019 levels following easing of lockdown
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
City Pub trading at 90% of 2019 levels following easing of lockdown | 28 June 2021
stockmarketwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockmarketwire.com Daily Mail and Mail on Sunday newspapers.